Work

A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Dordaviprone

Year: 2025

Type: article

Study design: Clinical Trial

Source: The Journal of Clinical Pharmacology

DOI: 10.1002/jcph.70129

Authors: Shamia L. Faison, Joelle Batonga, Thangam Arumugham, Angela Bartkus, Marion E. Morrison, Mark J. Mullin, Timothy Tippin, Odin Naderer

Institution: Chimerix (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416248037

FWCI:

Cites: 18

Cited by:

Related to: